Literature DB >> 15592307

Expression of aquaporin 9 in human chorioamniotic membranes and placenta.

Shengbiao Wang1, Jiexiong Chen, Marie Beall, Weidong Zhou, Michael G Ross.   

Abstract

OBJECTIVE: Aquaporin 9 (AQP9) is one of the recently identified water channels that is also permeable to neutral solutes including urea. To investigate the molecular mechanism of intramembranous pathway of amniotic fluid regulation, we sought to determine whether AQP9 is expressed, and the cellular localization of AQP9 expression in human fetal membranes. STUDY
DESIGN: Fetal membranes from 5 normal term human pregnancies were studied. Northern analysis was used to determine the tissue AQP9 messenger RNA (mRNA) expression. In situ hybridization and immunohistochemical staining with specific anti-AQP9 antibody was used for cellular AQP9 localization in the human fetal membranes.
RESULTS: Northern analysis detected AQP9 mRNA expression in human amnion, chorion, and placenta. In situ hybridization revealed AQP9 mRNA expression in epithelial cells of the amnion, chorion cytotrophoblasts, and syncytiotrophoblasts and cytotrophoblasts of placenta. Further immunohistochemical study confirmed the AQP9 protein expression in these cell types of fetal membranes.
CONCLUSION: This study demonstrated the expression of AQP9 mRNA and protein in human chorioamniotic membranes and placenta. The AQP9 expression in fetal membranes suggests that AQP9 may be an important water channel in intramembranous amniotic fluid water regulation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15592307     DOI: 10.1016/j.ajog.2004.05.089

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  8 in total

1.  Contribution of aquaporin 9 and multidrug resistance-associated protein 2 to differential sensitivity to arsenite between primary cultured chorion and amnion cells prepared from human fetal membranes.

Authors:  Yuta Yoshino; Bo Yuan; Toshikazu Kaise; Makoto Takeichi; Sachiko Tanaka; Toshihiko Hirano; Deanna L Kroetz; Hiroo Toyoda
Journal:  Toxicol Appl Pharmacol       Date:  2011-09-16       Impact factor: 4.219

2.  A Systematic Characterization of Aquaporin-9 Expression in Human Normal and Pathological Tissues.

Authors:  Cecilia Lindskog; Anna Asplund; Anca Catrina; Søren Nielsen; Michael Rützler
Journal:  J Histochem Cytochem       Date:  2016-03-29       Impact factor: 2.479

3.  Differential expression and regional distribution of aquaporins in amnion of normal and gestational diabetic pregnancies.

Authors:  Amy D Bednar; Michael K Beardall; Robert A Brace; Cecilia Y Cheung
Journal:  Physiol Rep       Date:  2015-03

4.  Trastuzumab administration during pregnancy: an update.

Authors:  Angeliki Andrikopoulou; Kleoniki Apostolidou; Spyridoula Chatzinikolaou; Garyfalia Bletsa; Eleni Zografos; Meletios-Athanasios Dimopoulos; Flora Zagouri
Journal:  BMC Cancer       Date:  2021-04-26       Impact factor: 4.430

Review 5.  The Relevance of Aquaporins for the Physiology, Pathology, and Aging of the Female Reproductive System in Mammals.

Authors:  Paweł Kordowitzki; Wiesława Kranc; Rut Bryl; Bartosz Kempisty; Agnieszka Skowronska; Mariusz T Skowronski
Journal:  Cells       Date:  2020-12-01       Impact factor: 6.600

6.  Lactic Acid Transport Mediated by Aquaporin-9: Implications on the Pathophysiology of Preeclampsia.

Authors:  Yollyseth Medina; Lucas Acosta; Julieta Reppetti; Ana Corominas; Juanita Bustamante; Natalia Szpilbarg; Alicia E Damiano
Journal:  Front Physiol       Date:  2021-12-02       Impact factor: 4.566

Review 7.  The Multifaceted Role of Aquaporin-9 in Health and Its Potential as a Clinical Biomarker.

Authors:  Inês V da Silva; Sabino Garra; Giuseppe Calamita; Graça Soveral
Journal:  Biomolecules       Date:  2022-06-27

8.  Aquaporin 1 affects pregnancy outcome and regulates aquaporin 8 and 9 expressions in the placenta.

Authors:  Hui Luo; Yi Liu; Yizuo Song; Ying Hua; Xueqiong Zhu
Journal:  Cell Tissue Res       Date:  2020-06-15       Impact factor: 5.249

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.